MDPile
SpecialtyNews
RSS icon
MDPile

  • New Hepatitis C Test Gains FDA Approval for Faster Diagnosis

    New Hepatitis C Test Gains FDA Approval for Faster Diagnosis

    7/10/2024

  • Revolutionary Hepatitis C Test Gains FDA Approval for Easier Diagnosis

    Revolutionary Hepatitis C Test Gains FDA Approval for Easier Diagnosis

    7/10/2024

  • Revolutionizing Hepatitis C Detection: FDA Approves Cepheid’s Rapid Test

    Revolutionizing Hepatitis C Detection: FDA Approves Cepheid’s Rapid Test

    6/28/2024

  • Breakthrough Macrophage Therapy for Liver Cirrhosis Gets Green Light

    Breakthrough Macrophage Therapy for Liver Cirrhosis Gets Green Light

    6/27/2024

  • Mazdutide Shows Promise in Slashing Liver Fat for Obesity Patients

    Mazdutide Shows Promise in Slashing Liver Fat for Obesity Patients

    6/25/2024

  • Promising New Treatment Under Study for Chronic Hepatitis B

    Promising New Treatment Under Study for Chronic Hepatitis B

    6/18/2024

  • Battle Against Fatty Liver Disease: Raising Awareness and Access to Treatment on Global Fatty Liver Day

    Battle Against Fatty Liver Disease: Raising Awareness and Access to Treatment on Global Fatty Liver Day

    6/13/2024

  • Breakthrough FDA Approval: Iqirvo® for Primary Biliary Cholangitis

    Breakthrough FDA Approval: Iqirvo® for Primary Biliary Cholangitis

    6/11/2024

  • Breakthrough MASH Treatment: ASC41 Shows Promising Results in Reducing Liver Fat

    Breakthrough MASH Treatment: ASC41 Shows Promising Results in Reducing Liver Fat

    6/11/2024

  • FDA accelerated approval: New Treatment for Primary Biliary Cholangitis

    FDA accelerated approval: New Treatment for Primary Biliary Cholangitis

    6/10/2024

  • New Hope in Treating Liver Disease: Tirzepatide Shows Promising Results

    New Hope in Treating Liver Disease: Tirzepatide Shows Promising Results

    6/9/2024

  • New Hope for Chronic Hepatitis B Sufferers: Promising Results from Phase 2 Trials

    New Hope for Chronic Hepatitis B Sufferers: Promising Results from Phase 2 Trials

    6/7/2024

  • Promising New Therapy Combination Shows Advances in Liver Disease Treatment

    Promising New Therapy Combination Shows Advances in Liver Disease Treatment

    6/5/2024

  • New Blood Test Offers Hope for Detecting and Monitoring Liver Disease

    New Blood Test Offers Hope for Detecting and Monitoring Liver Disease

    6/4/2024

  • Breakthrough Findings in Liver Biomarkers: POISE Trial Shows Promise for PBC Patients

    Breakthrough Findings in Liver Biomarkers: POISE Trial Shows Promise for PBC Patients

    6/4/2024

  • New Developments in Liver Health: Obeticholic Acid Shows Promising Results for PBC Patients

    New Developments in Liver Health: Obeticholic Acid Shows Promising Results for PBC Patients

    6/4/2024

  • New Device Improves Safety in Liver and Kidney Biopsies

    New Device Improves Safety in Liver and Kidney Biopsies

    6/4/2024

  • Promising 52-Week Results for VK2809 in Treating NASH and Fibrosis

    Promising 52-Week Results for VK2809 in Treating NASH and Fibrosis

    6/4/2024

  • New Hope in Treating Severe Alcohol-Associated Hepatitis: Surrozen's Phase 1b Clinical Trial

    New Hope in Treating Severe Alcohol-Associated Hepatitis: Surrozen's Phase 1b Clinical Trial

    6/4/2024

  • Breakthrough in NASH Treatment: Viking Therapeutics' VK2809 Shows Promising Results

    Breakthrough in NASH Treatment: Viking Therapeutics' VK2809 Shows Promising Results

    6/4/2024

  • Breakthrough in Liver Disease Treatment: Promising Results for SRT-015 Unveiled

    Breakthrough in Liver Disease Treatment: Promising Results for SRT-015 Unveiled

    5/29/2024

  • Promising New Insights into Hepatitis B Treatment at EASL™ 2024

    Promising New Insights into Hepatitis B Treatment at EASL™ 2024

    5/28/2024

  • New Stem Cell Therapy Shows Promise in Treating Liver Failure

    New Stem Cell Therapy Shows Promise in Treating Liver Failure

    5/23/2024

  • New Hope for Alcohol-Related Hepatitis: Larsucosterol Earns Breakthrough Status

    New Hope for Alcohol-Related Hepatitis: Larsucosterol Earns Breakthrough Status

    5/21/2024

  • Breakthrough for Severe Alcohol-Related Liver Disease: Larsucosterol Gains FDA Fast-Track Status

    Breakthrough for Severe Alcohol-Related Liver Disease: Larsucosterol Gains FDA Fast-Track Status

    5/21/2024

  • How Statins Can Help Reduce Liver Disease Risk in IBD Patients

    How Statins Can Help Reduce Liver Disease Risk in IBD Patients

    5/21/2024

  • Parental Obesity Greatly Increases Risk of Liver Disease in Adult Children

    Parental Obesity Greatly Increases Risk of Liver Disease in Adult Children

    5/20/2024

  • Bariatric Surgery Offers Lifeline in Reducing Liver Disease Mortality and Healthcare Costs

    Bariatric Surgery Offers Lifeline in Reducing Liver Disease Mortality and Healthcare Costs

    5/20/2024

  • New Hope for Liver Disease: Seladelpar Shows Promising Results in PBC Patients

    New Hope for Liver Disease: Seladelpar Shows Promising Results in PBC Patients

    5/19/2024

  • How Bariatric Surgery Can Transform Hospital Outcomes for NAFLD Patients

    How Bariatric Surgery Can Transform Hospital Outcomes for NAFLD Patients

    5/18/2024

  • FDA Calls for More Data on HEPLISAV-B for Hemodialysis Patients

    FDA Calls for More Data on HEPLISAV-B for Hemodialysis Patients

    5/14/2024

  • New Insights into Hepatitis C Treatment with Glecaprevir/Pibrentasvir

    New Insights into Hepatitis C Treatment with Glecaprevir/Pibrentasvir

    5/11/2024

  • Revolutionizing Early Detection of Liver Cancer in Hepatitis C Patients with New Biomarker Model

    Revolutionizing Early Detection of Liver Cancer in Hepatitis C Patients with New Biomarker Model

    5/11/2024

...
0
Terms & Conditions
Privacy Policy
MDPile